Vol 72, No 3 (2021)
Original paper
Published online: 2021-02-19

open access

Page views 1539
Article views/downloads 744
Get Citation

Connect on Social Media

Connect on Social Media

Endocrine dysfunction in children with Shwachman-Diamond syndrome

Agnieszka Bogusz-Wójcik1, Honorata Kołodziejczyk2, Elżbieta Moszczyńska1, Maja Klaudel-Dreszler3, Grzegorz Oracz4, Joanna Pawłowska3, Mieczysław Szalecki15
Pubmed: 33619711
Endokrynol Pol 2021;72(3):211-216.


Introduction: Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by pancreatic exocrine insufficiency, immune deficiency, bone marrow failure, and bone malformations. Systematic data concerning endocrine function in SDS are limited. We studied patients diagnosed in The Children’s Memorial Health Institute in Warsaw, Poland, to assess the prevalence of various endocrinopathies.

Material and methods: In the pilot study, retrospective data were collected for 5 patients with SDS. Subsequently, patients with SDS aged 3–16 years were recruited prospectively. In total, 19 patients with mutations in the SBDS gene were studied. Data were collected on anthropometric measurements, systemic screening tests of pituitary, thyroid, adrenal, pancreatic, and gonadal function, as well as bone mineral density. Descriptive statistics were tabulated and group differences assessed.

Results: Twelve patients (63%) had ≥ 1 endocrine disorder, including growth hormone dysfunction (10 patients, 53%), hypothyroidism (2 patients, 10%), congenital hypopituitarism (1 patient, 5%), and/or type 1 diabetes mellitus (T1DM) (1 patient, 5%). The group of boys presented with a significantly lower height (–2.1 SD, p < 0.0001) and BMI (–1.0 SD, p < 0.00001). The group of girls also showed significantly lower height (–2.6 SD, p < 0.00001) and BMI (–0.7 SD, p < 0.0001). All patients had significantly lower height than their mid-parental height. Delayed bone age was found in 15 patients (84%) and osteopaenia in 12 of 15 patients (80%).

Conclusions: Endocrine dysfunctions are common in SDS, especially growth hormone (GH) deficiency. Children with poor growth can benefit from an endocrinological evaluation and tests for GH deficiency. Bone mineral density measurements should be a part of a routine screening. Longitudinal studies are needed to better understand the aetiology and true prevalence of these disorders.

Article available in PDF format

View PDF Download PDF file


  1. Dror Y, Donadieu J, Koglmeier J, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011; 1242: 40–55.
  2. Cipolli M, Tridello G, Micheletto A, et al. Italian Registry Organization. Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old. BMJ Open. 2019; 9(1): e022617.
  3. Nelson AS, Myers KC. Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome. Hematol Oncol Clin North Am. 2018; 32(4): 687–700.
  4. Carapito R, Konantz M, Paillard C, et al. Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. J Clin Invest. 2017; 127(11): 4090–4103.
  5. Dhanraj S, Matveev A, Li H, et al. Biallelic mutations in cause Shwachman-Diamond syndrome. Blood. 2017; 129(11): 1557–1562.
  6. Tan S, Kermasson L, Hoslin A, et al. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome. Blood. 2019; 134(3): 277–290.
  7. Bezzerri V, Cipolli M. Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives. Mol Diagn Ther. 2019; 23(2): 281–290.
  8. Myers KC, Rose SR, Rutter MM, et al. Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome. J Pediatr. 2013; 162(6): 1235–40, 1240.e1.
  9. Bogusz-Wójcik A, Kołodziejczyk H, Klaudel-Dreszler M, et al. Somatic development in children with Shwachman-Diamond syndrome. Ital J Pediatr. 2020; 46(1): 151.
  10. Delaporta P, Sofocleous C, Economou M, et al. The Greek Registry of Shwachman Diamond-Syndrome: Molecular and clinical data. Pediatr Blood Cancer. 2017; 64(11).
  11. Goeteyn M. Ichthyosis, exocrine pancreatic insufficiency, impaired neutrophil chemotaxis, growth retardation, and metaphyseal dysplasia (Shwachman syndrome). Report of a case with extensive skin lesions (clinical, histological, and ultrastructural findings). Arch Dermatol. 1991; 127(2): 225–230.
  12. Rosendahl J, Teich N, Mossner J, et al. Compound heterozygous mutations of the SBDS gene in a patient with Shwachman-Diamond syndrome, type 1 diabetes mellitus and osteoporosis. Pancreatology. 2006; 6(6): 549–554.
  13. Gana S, Sainati L, Frau MR, et al. Shwachman-Diamond syndrome and type 1 diabetes mellitus: more than a chance association? Exp Clin Endocrinol Diabetes. 2011; 119(10): 610–612.
  14. Kamoda T, Saito T, Kinugasa H, et al. A case of Shwachman-Diamond syndrome presenting with diabetes from early infancy. Diabetes Care. 2005; 28(6): 1508–1509.
  15. Myers KC, Bolyard AA, Otto B, et al. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. J Pediatr. 2014; 164(4): 866–870.
  16. Jivani N, Torrado-Jule C, Vaiselbuh S, et al. A unique case of Shwachman-Diamond syndrome presenting with congenital hypopituitarism. J Pediatr Endocrinol Metab. 2016; 29(11): 1325–1327.
  17. Palczewska I. Indicators of the somatic development of Warsaw children and youth. Dev Period Med. 2001; 5(1): 17–118.
  18. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7): 1911–1930.
  19. Wejnarska K, Kołodziejczyk E, Ryżko J, et al. Comparison of 72-hour fecal fat quantification and the 13C-mixed triglyceride breath test in assessing pancreatic exocrine sufficiency in children with chronic pancreatitis. Dev Period Med. 2016; 20(3): 222–227.
  20. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999; 10(4): 259–264.
  21. Myers KC, Bolyard AA, Otto B, et al. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. J Pediatr. 2014; 164(4): 866–870.
  22. Furutani E, Shah AS, Zhao Y, et al. Inflammatory manifestations in patients with Shwachman-Diamond syndrome: A novel phenotype. Am J Med Genet A. 2020; 182(7): 1754–1760.
  23. Kornfeld SJ, Kratz J, Diamond F, et al. Shwachman-Diamond syndrome associated with hypogammaglobulinemia and growth hormone deficiency. J Allergy Clin Immunol. 1995; 96(2): 247–250.
  24. Mäkitie O, Ellis L, Durie PR, et al. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet. 2004; 65(2): 101–112.
  25. Toiviainen-Salo S, Mäyränpää MK, Durie PR, et al. Shwachman-Diamond syndrome is associated with low-turnover osteoporosis. Bone. 2007; 41(6): 965–972.
  26. Schaballie H, Renard M, Vermylen C, et al. Misdiagnosis as asphyxiating thoracic dystrophy and CMV-associated haemophagocytic lymphohistiocytosis in Shwachman-Diamond syndrome. Eur J Pediatr. 2013; 172(5): 613–622.